GRCL
Gracell Biotechnologies Inc.
485.20$
-2.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| – | – | – | 100.0% | – | – | |
| – | – | – | 100.0% | – | – | |
| – | – | – | 89,316.7% | – | – | |
| – | – | – | 37,442.6% | – | – | |
| – | – | – | 126,759.3% | – | – | |
| – | – | – | -126,659.3% | – | – | |
| – | – | – | 1,383.3% | – | – | |
| – | – | – | -123,430.1% | – | – | |
| – | – | – | 3,859.6% | – | – | |
| – | – | – | -127,289.6% | – | – | |
| – | – | – | -105,226.0% | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.